Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3 World

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Evidence: Percentage of Participants With Clinical Recovery Within 14 Days After Randomization - for Control in Nigella Sativa for COVID-19 OSF Preprint

Official URL: https://fevir.net/resources/Evidence/6514 Version: 1.0.0-ballot3
Standards status: Informative Computable Name: OSFPreprint_PrimaryOutcomeMeasure_0_OG001
Other Identifiers: FEvIR Object Identifier: FEvIR Object Identifier#6514, OID:2.16.840.1.113883.4.642.40.44.22.242

Copyright/Legal: https://creativecommons.org/licenses/by-nc-sa/4.0/

This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.

version: 1

ArtifactPublicationStatus: Active

url: Evidence Percentage of Participants With Clinical Recovery Within 14 Days After Randomization - for Control in Nigella Sativa for COVID-19 OSF Preprint

identifier: FEvIR Object Identifier/6514, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.22.242

version: 1.0.0-ballot3

name: OSFPreprint_PrimaryOutcomeMeasure_0_OG001

title: Percentage of Participants With Clinical Recovery Within 14 Days After Randomization - for Control in Nigella Sativa for COVID-19 OSF Preprint

status: Active

date: 2021-07-19 17:03:53+0000

author: Brian S. Alper:

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

description:

This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.

variableDefinition

description:

Control

note:

control group within study population: Adult symptomatic patients with mild COVID-19 were recruited between May and August 2020 from King Abdulaziz University Hospital in Jeddah, Saudi Arabia.

variableRole: Population

observed: standard of care medications alone

variableDefinition

description:

proportion of patients recovered (free of symptoms for 3 days) within 14 days after randomization

variableRole: Outcome

observed: EvidenceVariable Percentage of Participants With Clinical Recovery Within 14 Days After Randomization (NCT04401202)

statistic

description:

There were 47 patients in the treatment group (NSO) and 47 patients in the control group. The proportion of patients recovered in the treatment group was significantly higher than the control group, 37 (79%) versus 21 (45%) (p=0.001).

statisticType: Count of Participants

quantity: 21 Participants

SampleSizes

-KnownDataCount
*47